Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5. - Sachs J; Döhl K; Weber A; Bonus M; Ehlers F; Fleischer E; Klinger A; Gohlke H; Pietruszka J; Schmitt L; Teusch N (Frontiers in pharmacology, 2019)